E. Davioud et al., 18-VINYLDEOXYCORTICOSTERONE - A POTENT INHIBITOR OF THE BOVINE CYTOCHROME P-450(11-BETA), Bioorganic & medicinal chemistry, 6(10), 1998, pp. 1781-1788
18-Vinylprogesterone (18-VP) and 18-ethynylprogesterone (18-EP) have p
roved to be potent suicide inhibitors of P-450(11 beta), the last enzy
me of aldosterone biosynthesis (Delorme, C.; Piffeteau, A.; Viger, A.;
Marquet, A. fur. J. Biochem. 1995, 232, 247; Delorme, C.; Piffeteau,
A.; Sobrio, F.; Marquet, A. fur. J. Biochem. 1997, 248, 252). This pap
er describes the synthesis of 18-vinyldeoxycorticosterone (18-VDOC), a
n analogue of deoxycorticosterone (DOC), the physiological substrate o
f the enzyme, and the evaluation of its reversible inhibiting properti
es for deoxycorticosterone and corticosterone oxidation by the bovine
enzyme. 18-VDOC has been obtained by hydroxylation at C-21 of a 18-VP
precursor. Its reversible K-i values are, respectively, 0.3 mu M for t
he 11 beta-hydroxylation and 0.8 mu M for the 18-hydroxylation. Hence,
18-VDOC is the strongest competitive inhibitor of bovine P-450(11 bet
a) described so far, but in contrast with 18-VP, it does not inhibit m
ore efficiently the 18-hydroxylation than the 11-hydroxylation, (C) 19
98 Elsevier Science Ltd. All rights reserved.